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ABSTRACT 
The main purposes of this thesis were to analyse common genetic variation in candidate 
genes and candidate pathways in relation to breast cancer risk, prognosticators and 
survival, to develop statistical methods for genetic association analysis for evaluating 
the joint importance of genes, and to investigate the potential impact of adding genetic 
information to clinical risk factors for projecting individualised risk of developing 
breast cancer over specific time periods. 
 
In Paper I we studied genetic variation in the estrogen receptor α and epidermal growth 
factor genes in relation to breast cancer risk and survival. We located a region in the 
estrogen receptor α gene which showed a moderate signal for association with breast 
cancer risk but were unable to link common variation in the epidermal growth factor 
gene with breast cancer aetiology or prognosis.  
 
In Paper II we investigated whether suspected breast cancer risk SNPs within genes 
involved in androgen-to-estrogen conversion are associated with breast cancer 
prognosticators grade, lymph node status and tumour size. The strongest association 
was observed for a marker within the CYP19A1 gene with histological grade. We also 
found evidence that a second marker from the same gene is associated with histological 
grade and tumour size.  
 
In Paper III we developed a novel test of association which incorporates multivariate 
measures of categorical and continuous heterogeneity. In this work we described both a 
single-SNP and a global multi-SNP test and used simulated data to demonstrate the 
power of the tests when genetic effects differ across disease subtypes.  
 
In Paper IV we assessed the extent to which recently associated genetic risk variants 
improve breast cancer risk-assessment models. We investigated empirically the 
performance of eighteen breast cancer risk SNPs together with mammographic density 
and clinical risk factors in predicting absolute risk of breast cancer. We also examined 
the usefulness of various prediction models considered at a population level for a 
variety of individualised breast cancer screening approaches.  
 
The goal of a genetic association study is to establish statistical associations between 
genetic variants and disease states. Each variant linked to a disease can lead the way to 
a better understanding of the underlying biological mechanisms that govern the 
development of a disease. Increased knowledge of molecular variation provides the 
opportunity to stratify populations according to genetic makeup, which in turn has the 
potential to lead to improved disease prevention programs and improved patient care. 
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